Literature DB >> 28290493

Pancreatic cancer: New biomarkers improve standard screening.

Peter Sidaway.   

Abstract

Entities:  

Year:  2017        PMID： 28290493     DOI： 10.1038/nrclinonc.2017.35

Source DB:  PubMed          Journal:  Nat Rev Clin Oncol        ISSN： 1759-4774            Impact factor:   66.675


× No keyword cloud information.
  1 in total

1.  A Plasma Biomarker Panel to Identify Surgically Resectable Early-Stage Pancreatic Cancer.

Authors:  Seetharaman Balasenthil; Ying Huang; Suyu Liu; Tracey Marsh; Jinyun Chen; Sanford A Stass; Debra KuKuruga; Randall Brand; Nanyue Chen; Marsha L Frazier; J Jack Lee; Sudhir Srivastava; Subrata Sen; Ann McNeill Killary
Journal:  J Natl Cancer Inst       Date:  2017-08-01       Impact factor: 11.816
  1 in total
  3 in total

1.  Is mortality-to-incidence ratio associated with health disparity in pancreatic cancer? A cross-sectional database analysis of 57 countries.

Authors:  Hsiang-Lin Lee; Cheng-Ming Peng; Cheng-Yu Huang; Shin-Yi Wu; Ming-Chang Tsai; Chi-Chih Wang; Sung-Lang Chen; Chun-Che Lin; Chien-Ning Huang; Wen-Wei Sung
Journal:  BMJ Open       Date:  2018-07-06       Impact factor: 2.692

2.  Blockade of integrin α3 attenuates human pancreatic cancer via inhibition of EGFR signalling.

Authors:  Jungwhoi Lee; Jungsul Lee; Chulhee Choi; Jae Hoon Kim
Journal:  Sci Rep       Date:  2019-02-26       Impact factor: 4.379

3.  Identification of potential prognostic ceRNA module biomarkers in patients with pancreatic adenocarcinoma.

Authors:  Lili Zhao; Bingrong Liu
Journal:  Oncotarget       Date:  2017-10-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.